Novel Approaches to CRISPR Gene Editing in Cancer Treatment

ID: MS-2023-0042 • Nature Biotechnology • Submitted: Jul 12, 2023

CRISPR Gene Editing Cancer Oncology Molecular Biology

Under Review

Current Version: v2.0

Reviewers Needed: 3

Reviewer Matching

Our system has analyzed your manuscript content and keywords to suggest potential reviewers with relevant expertise.

25 potential reviewers identified

Content analysis complete

Conflict of interest screening applied

Filter by expertise

Filter by location

Exclude previous co-authors

Sort by:

Reviewer	Expertise	Publications	Match Score	Response Rate
Dr. Jennifer Zhang Stanford University	CRISPR Oncology Gene Therapy	78	95%	87%
Prof. Robert Kim MIT	Gene Editing Molecular Biology	92	92%	79%
Dr. Sarah Johnson University of Cambridge	Cancer Oncology CRISPR	64	89%	92%
Prof. David Lee Harvard Medical School	Gene Editing Cancer	103	85%	65%
Dr. Emily Chen University of Tokyo	Molecular Biology CRISPR	56	82%	88%

Previous Next

Showing 1 to 5 of 25 results

1 2 3 4 5

No reviewers selected yet. Select reviewers from the list above.

You need to select at least 3 reviewers before proceeding.

Powered by AI

Based on your manuscript's content and keywords, our AI system recommends the following actions:

Your manuscript would benefit from a reviewer with expertise in immunotherapy approaches.

Aim for geographical diversity in your reviewer selection for broader impact.

Include at least one reviewer with strong background in experimental design.

Dr. Jennifer Zhang has the highest likelihood of prompt review completion.